Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Acute Care Syndromic Testing Market Report 2025

Acute Care Syndromic Testing Global Market Report 2025 - By Disease Type (Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types), By Sample Type (Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types), By Target (Bacteria, Viruses, Fungi, Parasites), By End User (Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Acute Care Syndromic Testing Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Acute Care Syndromic Testing Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Acute Care Syndromic Testing Market?

Acute care syndromic testing refers to a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. It is used in emergency and critical care settings to quickly diagnose infectious diseases. This enables faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market are respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and other disease types. Respiratory diseases are infections that affect the lungs, airways, and respiratory tract, leading to symptoms such as coughing, shortness of breath, and fever. Various sample types used include blood, urine, biofluids, stool, swabs, and others. Targets for testing include bacteria, viruses, fungi, and parasites and it is used in settings such as hospitals, clinical and diagnostic laboratories, research and academic institutions, and others.

What Is The Acute Care Syndromic Testing Market Size 2025 And Growth Rate?

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.08 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increase in awareness of antimicrobial resistance, rise in government funding for infectious disease, increase in investment in healthcare infrastructure, increase focus on syndromic testing, expansion of telemedicine and rise in infectious disease.

What Is The Acute Care Syndromic Testing Market Growth Forecast?

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $7.50 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising prevalence of infectious diseases, growing demand for faster diagnostic solutions, expansion of healthcare services, rising use of multiplex syndromic panels, and growing geriatric population. Major trends in the forecast period include shift toward point-of-care testing, integration of cloud-based platforms, adoption of multiplex panels, development of AI-powered tools, and automation in syndromic testing.

Acute Care Syndromic Testing Market Size and growth rate 2025 to 2029: Graph

How Is The Acute Care Syndromic Testing Market Segmented?

The acute care syndromic testing market covered in this report is segmented –

1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types

2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types

3) By Target: Bacteria, Viruses, Fungi, Parasites

4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users

Subsegments:

1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases

2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases

3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases

4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases

5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Acute Care Syndromic Testing Market? Increasing Infectious Diseases Drive Demand For Rapid Diagnostic Solutions

The growing incidence of infectious diseases is expected to propel the acute care syndromic testing market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread from person to person, animals, or the environment. The growing incidence of infectious diseases is driven by factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change, increasing the need for effective prevention and treatment. Acute care syndromic testing is used in infectious diseases to rapidly identify pathogens and co-infections through multiplex molecular diagnostics, enabling targeted treatment decisions. For instance, in February 2024, according to the Health Security Agency, a UK-based government agency, in week 4 of 2024, the influenza positivity rate increased to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also rose, reaching 9.8 per 100,000 people, compared to 7.5 per 100,000 in the prior week. Additionally, influenza hospitalizations climbed to 7.63 per 100,000, up from 5.12 per 100,000 the week before. Therefore, the growing incidence of infectious diseases is driving the acute care syndromic testing market.

Who Are The Major Players In The Global Acute Care Syndromic Testing Market?

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

What Are The Key Trends Of The Global Acute Care Syndromic Testing Market? Advancements In Syndromic Testing Through Multiplex Real-Time PCR Technology

Major companies operating in the acute care syndromic testing market are focusing on technological advancements such as multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, reduce turnaround time, and improve patient outcomes through precise and timely treatment interventions. Multiplex real-time PCR technology is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single PCR reaction, improving efficiency and accuracy in disease diagnosis. For instance, in April 2023, QIAGEN N.V., a Netherlands-based biotechnology research company, launched the QIAstat-Dx syndromic testing solution in Japan, featuring a SARS-CoV-2 respiratory panel that detects over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it delivers rapid results with minimal labor compared to individual PCR assays. By the end of 2022, over 3,500 systems were installed globally, supporting the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. The system is available in over 100 countries, enhancing syndromic testing accessibility worldwide.

What Are Latest Mergers And Acquisitions In The Acute Care Syndromic Testing Market? Applied Biocode And Medline Partner To Expand Access To Multiplex Diagnostic Testing

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to improve access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP is a US-based healthcare company that manufactures and distributes medical supplies and provides healthcare services.

What Is The Regional Outlook For The Global Acute Care Syndromic Testing Market?

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Syndromic Testing  Market?

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Acute Care Syndromic Testing  Industry?

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including the acute care syndromic testing industry's global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Acute Care Syndromic Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $4.62 billion
Revenue Forecast In 2034 $7.50 billion
Growth Rate CAGR of 12.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The acute care syndromic testing market covered in this report is segmented –
1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types
2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types
3) By Target: Bacteria, Viruses, Fungi, Parasites
4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users Subsegments:
1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases
2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases
3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases
4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases
5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Acute Care Syndromic Testing Market Characteristics

    3. Acute Care Syndromic Testing Market Trends And Strategies

    4. Acute Care Syndromic Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Acute Care Syndromic Testing Growth Analysis And Strategic Analysis Framework

    5.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Acute Care Syndromic Testing Market Growth Rate Analysis

    5.4. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Acute Care Syndromic Testing Total Addressable Market (TAM)

    6. Acute Care Syndromic Testing Market Segmentation

    6.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Respiratory Diseases

    Gastrointestinal Diseases

    Genitourinary Diseases

    Tropical Diseases

    Other Disease Types

    6.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Blood

    Urine

    Biofluids

    Stool

    Swabs

    Other Sample Type

    6.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Bacteria

    Viruses

    Fungi

    Parasites

    6.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinical And Diagnostic Laboratories

    Research And Academic Institutions

    Other End Users

    6.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Influenza

    Respiratory Syncytial Virus (RSV)

    COVID-19

    Tuberculosis

    Other Respiratory Diseases

    6.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Clostridium Difficile Infection

    Norovirus

    Rotavirus

    Salmonella

    Other Gastrointestinal Diseases

    6.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Urinary Tract Infections (UTIs)

    Sexually Transmitted Infections (STIs)

    Vaginal Infections

    Other Genitourinary Diseases

    6.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Malaria

    Dengue

    Chikungunya

    Zika Virus

    Other Tropical Diseases

    6.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Meningitis

    Sepsis

    Other Emerging Infectious Diseases

    7. Acute Care Syndromic Testing Market Regional And Country Analysis

    7.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Acute Care Syndromic Testing Market

    8.1. Asia-Pacific Acute Care Syndromic Testing Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Acute Care Syndromic Testing Market

    9.1. China Acute Care Syndromic Testing Market Overview

    9.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Acute Care Syndromic Testing Market

    10.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Acute Care Syndromic Testing Market

    11.1. Japan Acute Care Syndromic Testing Market Overview

    11.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Acute Care Syndromic Testing Market

    12.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Acute Care Syndromic Testing Market

    13.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Acute Care Syndromic Testing Market

    14.1. South Korea Acute Care Syndromic Testing Market Overview

    14.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Acute Care Syndromic Testing Market

    15.1. Western Europe Acute Care Syndromic Testing Market Overview

    15.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Acute Care Syndromic Testing Market

    16.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Acute Care Syndromic Testing Market

    17.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Acute Care Syndromic Testing Market

    18.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Acute Care Syndromic Testing Market

    19.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Acute Care Syndromic Testing Market

    20.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Acute Care Syndromic Testing Market

    21.1. Eastern Europe Acute Care Syndromic Testing Market Overview

    21.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Acute Care Syndromic Testing Market

    22.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Acute Care Syndromic Testing Market

    23.1. North America Acute Care Syndromic Testing Market Overview

    23.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Acute Care Syndromic Testing Market

    24.1. USA Acute Care Syndromic Testing Market Overview

    24.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Acute Care Syndromic Testing Market

    25.1. Canada Acute Care Syndromic Testing Market Overview

    25.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Acute Care Syndromic Testing Market

    26.1. South America Acute Care Syndromic Testing Market Overview

    26.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Acute Care Syndromic Testing Market

    27.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Acute Care Syndromic Testing Market

    28.1. Middle East Acute Care Syndromic Testing Market Overview

    28.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Acute Care Syndromic Testing Market

    29.1. Africa Acute Care Syndromic Testing Market Overview

    29.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

    30.1. Acute Care Syndromic Testing Market Competitive Landscape

    30.2. Acute Care Syndromic Testing Market Company Profiles

    30.2.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

    31. Acute Care Syndromic Testing Market Other Major And Innovative Companies

    31.1. Seegene Inc.

    31.2. bioMérieux SA

    31.3. Sysmex Corporation

    31.4. Bio-Rad Laboratories Inc.

    31.5. QIAGEN N.V.

    31.6. Werfen

    31.7. DiaSorin S.p.A.

    31.8. Quidel Corporation

    31.9. Luminex Corporation

    31.10. Biocartis NV

    31.11. Microbiologics Inc.

    31.12. QuantuMDx Group Ltd.

    31.13. Curetis GmbH by OpGen Inc.

    31.14. Genetic Signatures Ltd.

    31.15. Applied BioCode Inc.

    32. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

    34. Recent Developments In The Acute Care Syndromic Testing Market

    35. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

    35.1 Acute Care Syndromic Testing Market In 2029 - Countries Offering Most New Opportunities

    35.2 Acute Care Syndromic Testing Market In 2029 - Segments Offering Most New Opportunities

    35.3 Acute Care Syndromic Testing Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Siemens Healthineers AG Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Danaher Corporation Financial Performance
  • Table 84: Becton, Dickinson and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Siemens Healthineers AG Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Danaher Corporation Financial Performance
  • Figure 84: Becton, Dickinson and Company Financial Performance

Global Anesthesia And Respiratory Devices Market 2022 – Market Opportunities And Strategies

Read More

The Diabetes Care Devices Market Share, Market Size, And Growth Rate 2022

Read More

The Drug Delivery Devices Market Share, Market Size, And Growth Rate 2022

Read More

Latest ENT Devices Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the surgical retractors market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the dental equipment and supplies marketresearch report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the diagnostic and monitoring ophthalmic devices and equipment market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the dental equipment and supplies market research report 2022 with industry size, share, segments and market growth

Read More

Post-Acute Care Global Market Report 2025 – By Service (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long Term Care Hospitals, Hospice Care, Home Healthcare Agencies, Other Services), By Conditions (Amputations, Wound Management, Brain Injury, Spinal Cord Injury, Neurological Disorders, Other Conditions), By Age (Elderly, Adult, Others), By Delivery Model (Hospital-Based, Freestanding, Home-Based), By Application (Chronic Care, Rehabilitation, Post-Acute Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acute Ischemic Stroke Diagnosis Global Market Report 2025 – By Diagnostic Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics), By Surgery Type (Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy), By Application (Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2025 – By Component (Software, Services, Hardware), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Other Diagnoses), By Modality (MRI (Magnetic Resonance Imaging), CT (Computed Tomography), X-ray, Ultrasound), By Application (In Vivo Diagnostics, In Vitro Diagnostics), By End-User (Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2025 – By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Myelodysplastic Syndrome Global Market Report 2025 – By Type (Myelodysplastic Syndrome With Unilineage Dysplasia, Myelodysplastic Syndrome With Multilineage Dysplasia, Myelodysplastic Syndrome With Ring Sideroblasts, Other Types), By Drug (Azacitidine, Lenalidomide, Decitabine, Deferasirox), By Treatment (Supportive Therapy, Growth Factors, Chemotherapy, Stem Cell Transplant, Other Treatments), By Route Of Administration (Oral, Injectable, Other Routes Of Administrations), By End-Users (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acute Coronary Syndrome Global Market Report 2025 – By Type (Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina), By Treatment (Medications, Statins, Beta blockers, ACE inhibitors, Anticoagulants, Other Treatment), By Diagnosis (Stress Test, Blood Tests, Imaging, Other Diagnosis), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Specialty clinics, Other End User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cough Hypersensitivity Syndrome Global Market Report 2025 – By Drug Class (Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs), By Route of Administration (Oral, Inhalation, Other Route Of Administration), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Acute Care Syndromic Testing market?

Acute care syndromic testing refers to a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. It is used in emergency and critical care settings to quickly diagnose infectious diseases. This enables faster treatment decisions, improved patient outcomes, and reduced hospital stays. For further insights on the Acute Care Syndromic Testing market, request a sample here

How will the Acute Care Syndromic Testing market drivers and restraints affect the market dynamics? What forces will shape the Acute Care Syndromic Testing industry going forward?

The Acute Care Syndromic Testing market major growth driver - Increasing Infectious Diseases Drive Demand For Rapid Diagnostic Solutions. For further insights on the Acute Care Syndromic Testing market, request a sample here

What is the forecast market size or the forecast market value of the Acute Care Syndromic Testing market?

The Acute Care Syndromic Testing market size has grown strongly in recent years. The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.08 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increase in awareness of antimicrobial resistance, rise in government funding for infectious disease, increase in investment in healthcare infrastructure, increase focus on syndromic testing, expansion of telemedicine and rise in infectious disease. The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $7.50 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising prevalence of infectious diseases, growing demand for faster diagnostic solutions, expansion of healthcare services, rising use of multiplex syndromic panels, and growing geriatric population. Major trends in the forecast period include shift toward point-of-care testing, integration of cloud-based platforms, adoption of multiplex panels, development of AI-powered tools, and automation in syndromic testing. For further insights on the Acute Care Syndromic Testing market, request a sample here

How is the Acute Care Syndromic Testing market segmented?

The acute care syndromic testing market covered in this report is segmented –
1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types
2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types
3) By Target: Bacteria, Viruses, Fungi, Parasites
4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users

Subsegments:
1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases
2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases
3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases
4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases
5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases For further insights on the Acute Care Syndromic Testing market, request a sample here

Which region has the largest share of the Acute Care Syndromic Testing market? What are the other regions covered in the report?

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Acute Care Syndromic Testing market, request a sample here.

Who are the major players in the Acute Care Syndromic Testing market?

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc. . For further insights on the Acute Care Syndromic Testing market, request a sample here.

What are the key trends in the Acute Care Syndromic Testing market?

Major trends in the Acute Care Syndromic Testing market include Advancements In Syndromic Testing Through Multiplex Real-Time PCR Technology. For further insights on the Acute Care Syndromic Testing market, request a sample here.

What are the major opportunities in the Acute Care Syndromic Testing market? What are the strategies for the Acute Care Syndromic Testing market?

For detailed insights on the major opportunities and strategies in the Acute Care Syndromic Testing market, request a sample here.

How does the Acute Care Syndromic Testing market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Acute Care Syndromic Testing market growth and SWOT analysis of the Acute Care Syndromic Testing industry, request a sample here.

For detailed insights on Acute Care Syndromic Testing's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Acute Care Syndromic Testing industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Acute Care Syndromic Testing industry,

What are the key dynamics influencing the Acute Care Syndromic Testing market growth? SWOT analysis of the Acute Care Syndromic Testing market. request a sample here.